Pharma Resources (Comparative Multiple Analysis)
Improve your investment analysis with by seeing the Pharma Resources's Discounted Cash Flow analysis, Pharma Resources's Warren Buffet analysis, and Pharma Resources's Weighted Average Cost of Capital (WACC) Analysis.
Notes on the Comparative Multiple Analysis of Pharma Resources
WikiWealth compares Pharma Resources's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Pharma Resources's comparative analysis.
Notes from the analysis:
1. WikiWealth uses quantitative measures to determine the multiple range for Pharma Resources.
Helpful Information for Pharma Resources's Analysis
How does this work? The Comparative Investment Analysis determines the value of Pharma Resources by comparing Pharma Resources financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.
Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Pharma Resources.
Also, see the Pharma Resources's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Pharma Resources's valuation conclusion for a quick summary.